SLDB Solid Biosciences Inc. Stock Quote

SLDB [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-2.05	Insider Own	23.60%	Shs Outstand	48.30M	Perf Week	-0.62%
Market Cap	386.87M	Forward P/E	-	EPS next Y	-1.03	Insider Trans	-0.20%	Shs Float	30.11M	Perf Month	-12.05%
Income	-98.80M	PEG	-	EPS next Q	-0.36	Inst Own	67.40%	Short Float	6.80%	Perf Quarter	82.39%
Sales	-	P/S	-	EPS this Y	-29.40%	Inst Trans	57.25%	Short Ratio	1.01	Perf Half Y	119.86%
Book/sh	0.46	P/B	13.96	EPS next Y	39.80%	ROA	-143.20%	Target Price	6.70	Perf Year	75.41%
Cash/sh	0.41	P/C	15.60	EPS next 5Y	-	ROE	-198.10%	52W Range	1.93 - 8.56	Perf YTD	-15.30%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-24.96%	Beta	-
Dividend %	-	Quick Ratio	1.80	Sales past 5Y	-	Gross Margin	-	52W Low	232.64%	ATR	0.76
Employees	121	Current Ratio	1.80	Sales Q/Q	-	Oper. Margin	-	RSI (14)	51.43	Volatility	7.62% 10.27%
Optionable	Yes	Debt/Eq	0.04	EPS Q/Q	34.60%	Profit Margin	-	Rel Volume	0.22	Prev Close	6.36
Shortable	Yes	LT Debt/Eq	0.03	Earnings	Nov 05 BMO	Payout	-	Avg Volume	2.04M	Price	6.42
Recom	3.20	SMA20	-7.08%	SMA50	23.80%	SMA200	86.80%	Volume	454,693	Change	0.94%

Jan-08-21

Upgrade

Credit Suisse

Underperform → Neutral

$2 → $7

Jul-28-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

May-07-20

Downgrade

Evercore ISI

Outperform → In-line

Oct-11-19

Initiated

Evercore ISI

Outperform

$22

Aug-29-19

Downgrade

Citigroup

Neutral → Sell

Aug-19-19

Upgrade

SVB Leerink

Mkt Perform → Outperform

$8 → $15

Aug-16-19

Upgrade

Chardan Capital Markets

Neutral → Buy

$7.50 → $10

May-14-19

Downgrade

Goldman

Neutral → Sell

$5 → $4

May-14-19

Downgrade

Credit Suisse

Neutral → Underperform

$7 → $6

Feb-08-19

Upgrade

Citigroup

Sell → Neutral

Feb-08-19

Downgrade

SVB Leerink

Outperform → Mkt Perform

Nov-06-18

Initiated

Citigroup

Sell

Sep-06-18

Initiated

Credit Suisse

Neutral

$38

Jan-22-21 07:00AM	Pfizer Stock 2021: A Lean, Mean, Covid-Fighting Machine? Investor's Business Daily
Jan-08-21 07:23PM	Sarepta Stock Dropped 50% After Gene-Therapy Setback. What to Do Now. Barrons.com -20.99%
04:30PM	Sarepta Tanks On Likely 2-Year Delay For Muscular Dystrophy Gene Therapy Investor's Business Daily
11:57AM	Why Solid Biosciences Stock Is Sinking Today Motley Fool
Jan-06-21 07:30AM	Solid Biosciences to Present at 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-04-21 09:34AM	Ultragenyx (RARE) Surges on Product Approvals, Pipeline Progress Zacks
Dec-24-20 04:00PM	Evolent Health and FireEye See Activist Action Barrons.com
Dec-11-20 02:36PM	Is SLDB A Good Stock To Buy Now? Insider Monkey +51.62%
07:30AM	Solid Biosciences Announces $90 Million Private Placement GlobeNewswire
Dec-09-20 07:51AM	New Strong Sell Stocks for December 9th Zacks
Dec-07-20 09:42AM	Are Options Traders Betting on a Big Move in Solid Biosciences (SLDB) Stock? Zacks
Nov-05-20 07:00AM	Solid Biosciences Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Nov-03-20 07:30AM	Solid Biosciences to Host Third Quarter 2020 Financial Results and Business Update Call on November 5, 2020 GlobeNewswire
Oct-28-20 03:03PM	Solid Biosciences (SLDB) to PostQ3 Earnings: What's in Store? Zacks
Oct-23-20 08:00AM	Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy GlobeNewswire +10.64%
Oct-09-20 08:54AM	Do Options Traders Know Something About Solid Biosciences (SLDB) Stock We Don't? Zacks
Oct-02-20 02:56PM	Solid Biosciences (SLDB) Stock Will Surge Over 200% From Current Levels, Says Analyst TipRanks +20.81%
07:30AM	Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 4th Annual Genetic Medicines Conference GlobeNewswire
Oct-01-20 02:56PM	Why Solid Biosciences Stock Has Doubled Today Barrons.com +70.44%
11:02AM	Why Solid Biosciences Stock Is Trading Higher Today Benzinga
07:30AM	Solid Biosciences Announces FDA Lifts Clinical Hold on IGNITE DMD Clinical Trial GlobeNewswire
Sep-11-20 02:45PM	SOLID BIOSCIENCES (SLDB) INVESTOR ALERT: Lawsuit Investigation ACCESSWIRE
Sep-10-20 10:19AM	FDA Delays Start of Sareptas Gene Therapy Trial. That Doesnt Faze the Stocks Bulls. Barrons.com
Aug-21-20 03:00PM	SOLID BIOSCIENCES (SLDB) INVESTOR ALERT: Lawsuit Investigation ACCESSWIRE
Jul-29-20 09:12PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Solid Biosciences Inc. - SLDB PR Newswire
Jul-28-20 12:50PM	Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Solid Biosciences Inc. (SLDB) Investigation ACCESSWIRE -6.27%
Jul-27-20 12:16PM	FDA Again Keeps Solid Biosciences Duchenne Trial On Clinical Hold TipRanks -10.53%
Jul-24-20 05:50PM	Solid Biosciences Provides Update Regarding the IGNITE DMD Phase I/II Clinical Hold GlobeNewswire
Jul-05-20 05:27PM	Solid Biosciences Inc. (SLDB): Hedge Fund Sentiment Unchanged Insider Monkey
Jun-18-20 07:00AM	Solid Biosciences Announces Appointment of Ian F. Smith as Chairman of the Board of Directors GlobeNewswire
Jun-12-20 06:45AM	Solid Biosciences (NASDAQ:SLDB) Will Have To Spend Its Cash Wisely Simply Wall St.
May-29-20 08:35AM	Why Solid Biosciences (SLDB) Stock Might be a Great Pick Zacks
May-22-20 07:00AM	Solid Biosciences to Hold Virtual Annual Meeting of Stockholders on June 16, 2020 GlobeNewswire
May-14-20 07:00AM	Solid Biosciences Presents Data from Duchenne Muscular Dystrophy Gene Therapy Program at ASGCT 23rd Annual Meeting GlobeNewswire
May-13-20 09:49AM	Top Ranked Momentum Stocks to Buy for May 13th Zacks
May-11-20 03:03AM	Solid Biosciences: Keep Your Eyes On The Prize Says Top Analyst SmarterAnalyst
May-09-20 01:48PM	Chardan Capital Sticks to Their Buy Rating for Solid Biosciences Llc Investing.com
May-07-20 07:22AM	Solid Biosciences Provides Update regarding SGT-001 Phase I/II Clinical Hold on IGNITE DMD GlobeNewswire -14.34%
Apr-16-20 07:00AM	Solid Biosciences Announces Appointment of Ian F. Smith to its Board of Directors GlobeNewswire
Mar-12-20 07:00AM	Solid Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update GlobeNewswire -7.01%
Jan-31-20 05:00AM	Families of rare-disease patients take on drug development, but face uphill battle American City Business Journals
Jan-22-20 11:48AM	New FDA documents shed light on agency's rejection of Sarepta drug American City Business Journals
Jan-10-20 10:08AM	Applied Genetic Stock Up on Favorable Eye Therapy Study Data Zacks -5.15%
Jan-09-20 08:00AM	Solid Biosciences Announces Organizational Changes to Prioritize Development of SGT-001 GlobeNewswire -14.45%
Dec-23-19 10:11AM	Sarepta Signs Gene Therapy Agreement With Roche for $1.15B Zacks
Dec-19-19 06:08PM	Is Solid Biosciences Inc. (SLDB) Going to Burn These Hedge Funds? Insider Monkey
Dec-18-19 08:46AM	Benzinga Pro's Top 5 Stocks To Watch For Wed., Dec. 18, 2019: UPS, MU, EPZM, SLDB, XXII Benzinga -17.40%
08:38AM	Solid Biosciences stock are up on DMD study news MarketWatch
06:30AM	Solid Biosciences Provides Data Update from SGT-001 Development Program GlobeNewswire
Dec-16-19 08:52AM	Options Traders Expect Huge Moves in Solid Biosciences (SLDB) Stock Zacks +8.15%
Dec-13-19 08:55AM	Sarepta's Vyondys 53 Receives FDA Approval for DMD, Stock Up Zacks
Nov-20-19 01:28PM	Hedge Fund Innovator Joseph Edelman Doubles Down on These 3 Biotech Stocks TipRanks
Nov-13-19 03:43PM	Biotech Stock Roundup: SLDB Plunges, CELG Gets FDA Nod for Reblozyl & Other Updates Zacks +8.51%
Nov-12-19 05:51PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Solid Biosciences Inc. - SLDB GlobeNewswire -74.36%
04:03PM	Biotech Pops After Rival's Gene Therapy Halted By Regulators Investor's Business Daily
10:56AM	FDA intervenes for 3rd time in Solid Biosciences' Duchenne drug tests American City Business Journals
10:22AM	Solid Biosciences Shares Crash To Record Low After FDA Places Gene Therapy Program On Hold Benzinga
10:15AM	Solid Biosciences Stock Crashes Over Safety Concerns About Its Gene Therapy Barrons.com
07:00AM	Solid Biosciences gene therapy trial put on hold by FDA Reuters
06:45AM	Solid Biosciences Provides SGT-001 Program Update GlobeNewswire
Oct-16-19 08:42AM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Solid Biosciences Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire +10.70%
Oct-02-19 07:30AM	Solid Biosciences to Participate in the Chardan 3rd Annual Genetic Medicines Conference GlobeNewswire
Sep-03-19 02:21PM	In expense-laden biotech industry, here are the Mass. startups most in need of cash American City Business Journals
Aug-29-19 11:38AM	Citi: Solid Biosciences Rally Unsupported By Fundamentals Benzinga -7.37%
09:02AM	Sell Solid Biosciences Stock Because Its Muscular Distrophy Drug Is Unlikely to Be Competitive Barrons.com
Aug-27-19 07:23AM	Will Solid Biosciences Continue to Surge Higher? Zacks
Aug-20-19 12:20PM	Sarepta's FDA rejection could have ripple effect in other Duchenne biotechs American City Business Journals
12:02PM	Parents Push One Rare-Disease Drug Through FDA, Not Its Successor Bloomberg
10:03AM	Sarepta Stock Falls as FDA Denies Approval to Golodirsen Zacks
Aug-19-19 03:17PM	Solid Biosciences Stock Surge Ignites Options Activity Schaeffer's Investment Research +5.56%
08:58AM	Solid Biosciences Surges on DMD Gene Therapy Study Amendments Zacks
Aug-16-19 12:15PM	Here's Why Solid Biosciences Is Soaring Today Motley Fool +43.25%
Aug-15-19 02:41PM	Sarepta's Lone Analyst Skeptic Takes On 22 Bulls With Renewed Warnings Bloomberg
Aug-14-19 07:25AM	Solid Biosciences Reports Second Quarter 2019 Financial Results and Provides Business Update GlobeNewswire +23.79%
Aug-08-19 10:33AM	Sarepta (SRPT) Q2 Loss Widens Y/Y, Golodirsen Nears Approval Zacks +7.50%
Jul-26-19 07:25AM	Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors GlobeNewswire +34.41%
Jul-01-19 09:35AM	Sarepta Up as Pfizer's DMD Gene Therapy Faces Safety Issues Zacks -9.04%
09:21AM	Pfizer's DMD Gene Therapy Shows Severe Side Effects in Study Zacks
Jun-28-19 06:51PM	Heres What Hedge Funds Think About Solid Biosciences Inc. (SLDB) Insider Monkey +13.86%
04:28PM	Gene Therapy Battle: Pfizer's Test Results Sent This Biotech Stock Flying Investor's Business Daily
Jun-12-19 04:04PM	Bain's second life sciences fund comes in over $1 billion American City Business Journals +5.25%
Jun-06-19 06:10PM	Vertex enters Duchenne field with $245M buy of Exonics American City Business Journals
May-16-19 03:00PM	Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Solid Biosciences Inc. (SLDB) GlobeNewswire
10:00AM	Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Solid Biosciences Inc. (SLDB) ACCESSWIRE
May-14-19 04:27PM	This Biotech Is More Than Its Lead Gene Therapies: Here Are 4 Drugs To Note Investor's Business Daily -28.59%
01:56PM	Solid Bios Plunge Sends a Warning on Gene Therapies Bloomberg
12:26PM	Here's Why Solid Biosciences Fell as Much as 40.9% Today Motley Fool
11:51AM	Solid Biosciences Tanks After Reporting Adverse Event In Duchenne Muscular Dystrophy Trial Benzinga
07:42AM	The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings Benzinga
May-13-19 04:10PM	Solid Biosciences Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
May-03-19 10:13AM	Heres What Hedge Funds Think About About Solid Biosciences Inc. (SLDB) Insider Monkey
Apr-17-19 11:10AM	Wave Life Sciences Plunges After DMD Study Data Readout Zacks
Apr-16-19 02:39PM	Bain Capital raising another life sciences fund after $720M debut American City Business Journals
Apr-15-19 04:01PM	Solid Biosciences Announces Upcoming Preclinical Data Presentations at The American Society of Gene and Cell Therapy Annual Meeting GlobeNewswire
Apr-08-19 09:45AM	4 Gene Therapy Players Likely to Become Buyout Targets in 2019 Zacks
Mar-28-19 10:20AM	Sarepta plans second Duchenne drug application this year American City Business Journals
Mar-13-19 07:30AM	Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update GlobeNewswire
Mar-10-19 10:36AM	10 Stocks For The Gene Therapy Revolution Investopedia
Feb-27-19 09:53AM	The Zacks Analyst Blog Highlights: Spark Therapeutics, Solid Biosciences, REGENXBIO, Editas Medicine and uniQure Zacks
Feb-26-19 11:15AM	Biotech ETFs Jump on Roche-Spark Deal Zacks

Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to derive functional dystrophin protein expression in patients' muscles. Its portfolio also comprises Anti-LTBP4, a complementary disease modifying program that identifies and develops a monoclonal antibody intended to reduce fibrosis and inflammation by targeting and stabilizing the LTBP4 protein. In addition, the company engages in developing biomarkers and sensors; and Solid Suit program that includes the development of wearable assistive devices that focus on providing functional and therapeutic benefits. Solid Biosciences Inc. has strategic collaboration with Ultragenyx to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ganot Ilan	CEO & President	Aug 13	Sale	2.44	299	730	3,483	Aug 14 04:07 PM
Morris Carl Ashley	Chief Scientific Officer	Jul 28	Sale	2.42	3,591	8,689	290,959	Jul 29 05:37 PM
Ziolkowski Jennifer Lynn	CFO, Treasurer & Asst. Secy	Jul 28	Sale	2.42	3,591	8,687	327,609	Jul 29 05:33 PM
HERSCHA LYNETTE	Chief Legal Officer	Jul 28	Sale	2.42	5,141	12,438	160,859	Jul 29 05:28 PM
Ganot Ilan	CEO & President	Jul 28	Sale	2.42	11,124	26,910	1,148,007	Jul 29 05:23 PM
Schneider Joel Solomon Zev	Chief Technology Officer	Jul 28	Sale	2.42	4,041	9,776	284,115	Jul 29 07:26 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience